Sandeep Yarlagadda, MD | |
9700 N Saguaro Blvd, Fountain Hills, AZ 85268-6241 | |
(509) 715-1330 | |
Not Available |
Full Name | Sandeep Yarlagadda |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 20 Years |
Location | 9700 N Saguaro Blvd, Fountain Hills, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1497872402 | NPI | - | NPPES |
923170 | Medicaid | AZ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | MD437639 (Pennsylvania) | Secondary |
207R00000X | Internal Medicine | 48970 (Arizona) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Fhmc Clinic | 8729497706 | 9 |
News Archive
"At present, it can take up to a year before a patient is diagnosed with SLE. This is because the symptoms are diffuse and are often mistaken for other diseases. However, with this blood-based test, it is possible to determine quickly whether someone has the disease or not", says Christer Wingren, associate professor in Immunotechnology at CREATE Health, Lund University.
Once Salmonella bacteria get into a food processing facility and have an opportunity to form a biofilm on surfaces, it is likely to be extraordinarily difficult, if not impossible, to kill it, according to research published ahead of print in the journal Applied and Environmental Microbiology.
Infinity Pharmaceuticals, Inc. today announced interim data from its Phase 2, double-blind, randomized, placebo-controlled study of saridegib (IPI-926) in patients with metastatic or locally advanced, inoperable chondrosarcoma. The primary endpoint of the Phase 2 study was progression-free survival.
New hospital fees and provider cuts in Georgia and California aim to make their Medicaid programs more solvent, but fights over details are keeping the plans shelved for now.
The Food and Drug Administration (FDA) in the United States has issued a warning to drug manufacturers, suppliers and health professionals that counterfeit drug additives have been using diethyline glycol, or DEG as a substitute for glycerin in cough medicine, fever medication and injectable drugs.
› Verified 8 days ago
Entity Name | Hospitalists Of Arizona, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578564860 PECOS PAC ID: 2163335290 Enrollment ID: O20031112000571 |
News Archive
"At present, it can take up to a year before a patient is diagnosed with SLE. This is because the symptoms are diffuse and are often mistaken for other diseases. However, with this blood-based test, it is possible to determine quickly whether someone has the disease or not", says Christer Wingren, associate professor in Immunotechnology at CREATE Health, Lund University.
Once Salmonella bacteria get into a food processing facility and have an opportunity to form a biofilm on surfaces, it is likely to be extraordinarily difficult, if not impossible, to kill it, according to research published ahead of print in the journal Applied and Environmental Microbiology.
Infinity Pharmaceuticals, Inc. today announced interim data from its Phase 2, double-blind, randomized, placebo-controlled study of saridegib (IPI-926) in patients with metastatic or locally advanced, inoperable chondrosarcoma. The primary endpoint of the Phase 2 study was progression-free survival.
New hospital fees and provider cuts in Georgia and California aim to make their Medicaid programs more solvent, but fights over details are keeping the plans shelved for now.
The Food and Drug Administration (FDA) in the United States has issued a warning to drug manufacturers, suppliers and health professionals that counterfeit drug additives have been using diethyline glycol, or DEG as a substitute for glycerin in cough medicine, fever medication and injectable drugs.
› Verified 8 days ago
Entity Name | Mt Graham Regional Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1275588345 PECOS PAC ID: 6204822364 Enrollment ID: O20040423000105 |
News Archive
"At present, it can take up to a year before a patient is diagnosed with SLE. This is because the symptoms are diffuse and are often mistaken for other diseases. However, with this blood-based test, it is possible to determine quickly whether someone has the disease or not", says Christer Wingren, associate professor in Immunotechnology at CREATE Health, Lund University.
Once Salmonella bacteria get into a food processing facility and have an opportunity to form a biofilm on surfaces, it is likely to be extraordinarily difficult, if not impossible, to kill it, according to research published ahead of print in the journal Applied and Environmental Microbiology.
Infinity Pharmaceuticals, Inc. today announced interim data from its Phase 2, double-blind, randomized, placebo-controlled study of saridegib (IPI-926) in patients with metastatic or locally advanced, inoperable chondrosarcoma. The primary endpoint of the Phase 2 study was progression-free survival.
New hospital fees and provider cuts in Georgia and California aim to make their Medicaid programs more solvent, but fights over details are keeping the plans shelved for now.
The Food and Drug Administration (FDA) in the United States has issued a warning to drug manufacturers, suppliers and health professionals that counterfeit drug additives have been using diethyline glycol, or DEG as a substitute for glycerin in cough medicine, fever medication and injectable drugs.
› Verified 8 days ago
Entity Name | Arizona Inpatient Medicine Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1083647754 PECOS PAC ID: 4183688344 Enrollment ID: O20041117000307 |
News Archive
"At present, it can take up to a year before a patient is diagnosed with SLE. This is because the symptoms are diffuse and are often mistaken for other diseases. However, with this blood-based test, it is possible to determine quickly whether someone has the disease or not", says Christer Wingren, associate professor in Immunotechnology at CREATE Health, Lund University.
Once Salmonella bacteria get into a food processing facility and have an opportunity to form a biofilm on surfaces, it is likely to be extraordinarily difficult, if not impossible, to kill it, according to research published ahead of print in the journal Applied and Environmental Microbiology.
Infinity Pharmaceuticals, Inc. today announced interim data from its Phase 2, double-blind, randomized, placebo-controlled study of saridegib (IPI-926) in patients with metastatic or locally advanced, inoperable chondrosarcoma. The primary endpoint of the Phase 2 study was progression-free survival.
New hospital fees and provider cuts in Georgia and California aim to make their Medicaid programs more solvent, but fights over details are keeping the plans shelved for now.
The Food and Drug Administration (FDA) in the United States has issued a warning to drug manufacturers, suppliers and health professionals that counterfeit drug additives have been using diethyline glycol, or DEG as a substitute for glycerin in cough medicine, fever medication and injectable drugs.
› Verified 8 days ago
Entity Name | Arizona Acute Medical Services 1 Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154860674 PECOS PAC ID: 6204113970 Enrollment ID: O20170505001284 |
News Archive
"At present, it can take up to a year before a patient is diagnosed with SLE. This is because the symptoms are diffuse and are often mistaken for other diseases. However, with this blood-based test, it is possible to determine quickly whether someone has the disease or not", says Christer Wingren, associate professor in Immunotechnology at CREATE Health, Lund University.
Once Salmonella bacteria get into a food processing facility and have an opportunity to form a biofilm on surfaces, it is likely to be extraordinarily difficult, if not impossible, to kill it, according to research published ahead of print in the journal Applied and Environmental Microbiology.
Infinity Pharmaceuticals, Inc. today announced interim data from its Phase 2, double-blind, randomized, placebo-controlled study of saridegib (IPI-926) in patients with metastatic or locally advanced, inoperable chondrosarcoma. The primary endpoint of the Phase 2 study was progression-free survival.
New hospital fees and provider cuts in Georgia and California aim to make their Medicaid programs more solvent, but fights over details are keeping the plans shelved for now.
The Food and Drug Administration (FDA) in the United States has issued a warning to drug manufacturers, suppliers and health professionals that counterfeit drug additives have been using diethyline glycol, or DEG as a substitute for glycerin in cough medicine, fever medication and injectable drugs.
› Verified 8 days ago
Entity Name | Fhmc Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043830623 PECOS PAC ID: 8729497706 Enrollment ID: O20210503002389 |
News Archive
"At present, it can take up to a year before a patient is diagnosed with SLE. This is because the symptoms are diffuse and are often mistaken for other diseases. However, with this blood-based test, it is possible to determine quickly whether someone has the disease or not", says Christer Wingren, associate professor in Immunotechnology at CREATE Health, Lund University.
Once Salmonella bacteria get into a food processing facility and have an opportunity to form a biofilm on surfaces, it is likely to be extraordinarily difficult, if not impossible, to kill it, according to research published ahead of print in the journal Applied and Environmental Microbiology.
Infinity Pharmaceuticals, Inc. today announced interim data from its Phase 2, double-blind, randomized, placebo-controlled study of saridegib (IPI-926) in patients with metastatic or locally advanced, inoperable chondrosarcoma. The primary endpoint of the Phase 2 study was progression-free survival.
New hospital fees and provider cuts in Georgia and California aim to make their Medicaid programs more solvent, but fights over details are keeping the plans shelved for now.
The Food and Drug Administration (FDA) in the United States has issued a warning to drug manufacturers, suppliers and health professionals that counterfeit drug additives have been using diethyline glycol, or DEG as a substitute for glycerin in cough medicine, fever medication and injectable drugs.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Sandeep Yarlagadda, MD 9700 N Saguaro Blvd, Fountain Hills, AZ 85268-6241 Ph: (602) 671-7990 | Sandeep Yarlagadda, MD 9700 N Saguaro Blvd, Fountain Hills, AZ 85268-6241 Ph: (509) 715-1330 |
News Archive
"At present, it can take up to a year before a patient is diagnosed with SLE. This is because the symptoms are diffuse and are often mistaken for other diseases. However, with this blood-based test, it is possible to determine quickly whether someone has the disease or not", says Christer Wingren, associate professor in Immunotechnology at CREATE Health, Lund University.
Once Salmonella bacteria get into a food processing facility and have an opportunity to form a biofilm on surfaces, it is likely to be extraordinarily difficult, if not impossible, to kill it, according to research published ahead of print in the journal Applied and Environmental Microbiology.
Infinity Pharmaceuticals, Inc. today announced interim data from its Phase 2, double-blind, randomized, placebo-controlled study of saridegib (IPI-926) in patients with metastatic or locally advanced, inoperable chondrosarcoma. The primary endpoint of the Phase 2 study was progression-free survival.
New hospital fees and provider cuts in Georgia and California aim to make their Medicaid programs more solvent, but fights over details are keeping the plans shelved for now.
The Food and Drug Administration (FDA) in the United States has issued a warning to drug manufacturers, suppliers and health professionals that counterfeit drug additives have been using diethyline glycol, or DEG as a substitute for glycerin in cough medicine, fever medication and injectable drugs.
› Verified 8 days ago
Dr. Douglas Robinson, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 10624 N Crestview Dr, Fountain Hills, AZ 85268 Phone: 202-489-3622 | |
Dylan Doss, D.O. Internal Medicine Medicare: Medicare Enrolled Practice Location: 16857 E Saguaro Blvd, Fountain Hills, AZ 85268 Phone: 480-626-9578 Fax: 920-241-1167 | |
Dr. Chukwuemeka N Ezeume, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9700 N Saguaro Blvd, Fountain Hills, AZ 85268 Phone: 602-671-7990 | |
Dr. Parminder Singh Sidhu, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 16838 E Palisades Blvd Ste 153, Fountain Hills, AZ 85268 Phone: 480-816-3131 Fax: 844-207-3461 | |
Jyoti R Patel, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 13620 N Saguaro Blvd, Suite 100, Fountain Hills, AZ 85268 Phone: 480-816-3131 Fax: 480-816-3136 | |
Jodi K Novak, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 16838 E Palisades Blvd Ste 153, Fountain Hills, AZ 85268 Phone: 480-816-3131 Fax: 844-207-3461 |